Anteco Pharma is a contract manufacturer (CMO) for the pharmaceutical, medical device and nutritional supplement industries. Services include process development, transfer and scale-up; formulation; lyophilization (bulk & vial); aseptic filling; and drug & device packaging. Representative products include diagnostic reagents, wound management products and nutraceutical ingredients. The company’s pharmaceutical focus is on small volume clinical and pre-clinical manufacturing. Anteco Pharma is registered with the US FDA as both a drug and medical device manufacturer. The company is ISO 9001 and ISO 13485 certified.
Aurora is a private non-profit integrated health care system incorporating leading-edge research and evidence-based best practice into high-quality patient care. As Wisconsin’s largest health care system, with 15 medical centers and hospitals, 185 clinic sites and a team of 3,600 physicians, Aurora has hundreds of active industry and government sponsored clinical trials at any given time.
BioForward is the member-driven state association that is the voice of Wisconsin’s bioscience industry. We advocate actively on our members’ behalf for public policy that supports the industry, save our members money through our Select Savings group purchasing program, and provide a variety of opportunities for connections to funding, partners, customers, employers and employees through our events and online re- sources. Our professional, service-oriented staff also provide one-on-one support to members.
Deltanoid Pharmaceuticals Inc. is a privately held company conducting preclinical and clinical research on novel vitamin D analogs and other compounds in a wide variety of therapeutic areas, including osteoporosis, renal health and dermatology.
For 30 years, DNASTAR has been creating powerful life science software for visualizing and analyzing DNA, RNA, and protein sequences. Since the beginning, the company has focused on providing easy-to-use software tools for life scientists. Today, DNASTAR is growing its product offerings in support of clinical research applications with tools that handle sequence data from all the leading technology platforms in projects of any size or complexity.
ENDECE is dedicated to designing and developing new drugs that con- trol specific genes in biological pathways for the purpose of treating human disease.
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company is in the process of testing an investigational non- invasive, molecular screening test for the detection of colorectal cancer and pre-cancer. Exact Sciences began enrollment in their pivotal study in June 2011. The prospective, multicenter study, referred to as “DeeP-C”, will generate data to support Exact Sciences’ planned PMA submission to the U.S. Food and Drug Administration.
FluGen is the emerging leader in the fusion of intradermal delivery and vaccine biology. The company has differentiating technologies that en- able it to create value and compete in the large, rapidly growing influ- enza vaccine market.
Forte Research Systems develops clinical and translational research man- agement software. OnCore®, Forte’s flagship product, is the most widely adopted, enterprise-class clinical research management system among academic health centers, research hospitals, and cancer centers in the United States. The company’s newest offering is the cloud-based Allegro® Research on Demand product line. Allegro CTMS@SiteTM is a clinical trial management system designed for investigator sites and research groups engaged in industry-sponsored clinical trials. Allegro CTMS@Network is a clinical trial management system for trial and site management organi- zations and investigator site networks.
Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women. At Hologic, we are on a mission to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design and every investment we make.
The Clinical Research Center at Marshfield Clinic Research Foundation provides centralized comprehensive services to ensure quality and ef- ficiency in conducting clinical research of drugs, devices and biotechnol- ogy. Our center provides expertise in industry and investigator initiated federal and non-federal funded projects and provides access to a large tertiary care center of 54 clinics, affiliated hospitals and collaborative or- ganizations.
Quintessence Biosciences, Inc. is a private, clinical stage biopharmaceuti- cal company developing novel anti-cancer compounds based on the pat- ented EVade™ Ribonuclease technology.
A Phase 1 Clinical Research Unit and Cardiac Core Lab located just north of Milwaukee, Wisconsin. We conduct all types of Phase 1 clinical trials and can manage projects from protocol design through completion of the clinical summaries with our data management, biostatistics, and medical writing unit. Additionally, we provide cardiac core lab services in sup- port of Phase 1 through 4 studies around the world. We are also a medi- cal device company, and have our own proprietary ECG device, purpose built to be utilized in clinical research studies.
A pioneer in the medical rehabilitation device industry, VibeTech, Inc. improves people’s health, independence and quality of life through vibration science. The company’s cornerstone product, the VibeTech One (TM) semi-recumbent vibration therapy system, is the only comprehensive solution to muscle disuse atrophy and functional decline, especially in the most difficult patients to treat—those with mobility impairments. Beyond VibeTech One, no other established treatment modality, including electronic stimulation, continuous passive motion, or ultrasound/diathermy, provides the comprehensive solution to satisfy all market needs.